Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

2013 ◽  
Vol 58 (3) ◽  
pp. 495-501 ◽  
Author(s):  
Eiichi Ogawa ◽  
Norihiro Furusyo ◽  
Eiji Kajiwara ◽  
Kazuhiro Takahashi ◽  
Hideyuki Nomura ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Multicenter Study ◽  
Pegylated Interferon ◽  
Prospective Multicenter Study ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Pegylated interferon alpha 2b for chronic hepatitis C

2009 ◽  
Author(s):  
Tahany Awad ◽  
Kristian Thorlund ◽  
Goran Hauser ◽  
Mahasen Mabrouk ◽  
Davor Stimac ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

AIDS ◽  
2004 ◽  
Vol 18 (1) ◽  
pp. 131
Author(s):  
Steven Callens ◽  
Emmanuel Bottieau ◽  
Peter Michielsen ◽  
Robert Colebunders
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B
Sign in / Sign up

Export Citation Format

Share Document